Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications
Clinical trial NCT01455090 · COMPLETED
Trial details
- NCT number
- NCT01455090
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-30
- Primary completion
- 2014-03-31
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.